News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PhytoMedical Technologies, Inc. (PYTO.OB)’s In Vivo Toxicity and Efficacy Tests on Human Colon Cancer Deliver Promising Results


10/27/2008 10:06:25 AM

PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced the results of its anti-cancer compound in vivo toxicity and efficacy tests on HCT116 human colon cancer cells was successful. “I am encouraged by the results of our human colon cancer toxicity and efficacy tests which is allowing us to continue to climb our developmental ladder,” stated Mr. Greg Wujek, President and CEO of PhytoMedical Technologies, Inc. “We have made some significant progress this past year and look forward to moving to the next phase in our developmental pathway.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES